Fatty acid analogue N-arachidonoyl taurine restores function of IKs channels with diverse long QT mutations

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Standard

Fatty acid analogue N-arachidonoyl taurine restores function of IKs channels with diverse long QT mutations. / Liin, Sara I; Larsson, Johan E; Barro-Soria, Rene; Bentzen, Bo Hjorth; Larsson, H Peter.

I: eLife, Bind 5, e20272, 30.09.2016.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Harvard

Liin, SI, Larsson, JE, Barro-Soria, R, Bentzen, BH & Larsson, HP 2016, 'Fatty acid analogue N-arachidonoyl taurine restores function of IKs channels with diverse long QT mutations', eLife, bind 5, e20272. https://doi.org/10.7554/eLife.20272

APA

Liin, S. I., Larsson, J. E., Barro-Soria, R., Bentzen, B. H., & Larsson, H. P. (2016). Fatty acid analogue N-arachidonoyl taurine restores function of IKs channels with diverse long QT mutations. eLife, 5, [e20272]. https://doi.org/10.7554/eLife.20272

Vancouver

Liin SI, Larsson JE, Barro-Soria R, Bentzen BH, Larsson HP. Fatty acid analogue N-arachidonoyl taurine restores function of IKs channels with diverse long QT mutations. eLife. 2016 sep. 30;5. e20272. https://doi.org/10.7554/eLife.20272

Author

Liin, Sara I ; Larsson, Johan E ; Barro-Soria, Rene ; Bentzen, Bo Hjorth ; Larsson, H Peter. / Fatty acid analogue N-arachidonoyl taurine restores function of IKs channels with diverse long QT mutations. I: eLife. 2016 ; Bind 5.

Bibtex

@article{f72e812eeb5d44ee95672cbb5ab9b008,
title = "Fatty acid analogue N-arachidonoyl taurine restores function of IKs channels with diverse long QT mutations",
abstract = "About 300 loss-of-function mutations in the IKs channel have been identified in patients with Long QT syndrome and cardiac arrhythmia. How specific mutations cause arrhythmia is largely unknown and there are no approved IKs channel activators for treatment of these arrhythmias. We find that several Long QT syndrome-associated IKs channel mutations shift channel voltage dependence and accelerate channel closing. Voltage-clamp fluorometry experiments and kinetic modeling suggest that similar mutation-induced alterations in IKs channel currents may be caused by different molecular mechanisms. Finally, we find that the fatty acid analogue N-arachidonoyl taurine restores channel gating of many different mutant channels, even though the mutations are in different domains of the IKs channel and affect the channel by different molecular mechanisms. N-arachidonoyl taurine is therefore an interesting prototype compound that may inspire development of future IKs channel activators to treat Long QT syndrome caused by diverse IKs channel mutations.",
author = "Liin, {Sara I} and Larsson, {Johan E} and Rene Barro-Soria and Bentzen, {Bo Hjorth} and Larsson, {H Peter}",
year = "2016",
month = sep,
day = "30",
doi = "10.7554/eLife.20272",
language = "English",
volume = "5",
journal = "eLife",
issn = "2050-084X",
publisher = "eLife Sciences Publications Ltd.",

}

RIS

TY - JOUR

T1 - Fatty acid analogue N-arachidonoyl taurine restores function of IKs channels with diverse long QT mutations

AU - Liin, Sara I

AU - Larsson, Johan E

AU - Barro-Soria, Rene

AU - Bentzen, Bo Hjorth

AU - Larsson, H Peter

PY - 2016/9/30

Y1 - 2016/9/30

N2 - About 300 loss-of-function mutations in the IKs channel have been identified in patients with Long QT syndrome and cardiac arrhythmia. How specific mutations cause arrhythmia is largely unknown and there are no approved IKs channel activators for treatment of these arrhythmias. We find that several Long QT syndrome-associated IKs channel mutations shift channel voltage dependence and accelerate channel closing. Voltage-clamp fluorometry experiments and kinetic modeling suggest that similar mutation-induced alterations in IKs channel currents may be caused by different molecular mechanisms. Finally, we find that the fatty acid analogue N-arachidonoyl taurine restores channel gating of many different mutant channels, even though the mutations are in different domains of the IKs channel and affect the channel by different molecular mechanisms. N-arachidonoyl taurine is therefore an interesting prototype compound that may inspire development of future IKs channel activators to treat Long QT syndrome caused by diverse IKs channel mutations.

AB - About 300 loss-of-function mutations in the IKs channel have been identified in patients with Long QT syndrome and cardiac arrhythmia. How specific mutations cause arrhythmia is largely unknown and there are no approved IKs channel activators for treatment of these arrhythmias. We find that several Long QT syndrome-associated IKs channel mutations shift channel voltage dependence and accelerate channel closing. Voltage-clamp fluorometry experiments and kinetic modeling suggest that similar mutation-induced alterations in IKs channel currents may be caused by different molecular mechanisms. Finally, we find that the fatty acid analogue N-arachidonoyl taurine restores channel gating of many different mutant channels, even though the mutations are in different domains of the IKs channel and affect the channel by different molecular mechanisms. N-arachidonoyl taurine is therefore an interesting prototype compound that may inspire development of future IKs channel activators to treat Long QT syndrome caused by diverse IKs channel mutations.

U2 - 10.7554/eLife.20272

DO - 10.7554/eLife.20272

M3 - Journal article

C2 - 27690226

VL - 5

JO - eLife

JF - eLife

SN - 2050-084X

M1 - e20272

ER -

ID: 173130697